Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Celine Perier
Affiliation
Vall d'Hebron Research Institute (VHIR)
ORCID
Career Start Year
2000
Papers
46
H Index
34
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37726343
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.
NPJ Parkinsons Dis
2023
35285474
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.
Brain
2022
35730550
Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.
Glob Health Action
2022
33902111
Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice.
Hum Mol Genet
2021
32426502
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates.
Sci Adv
2020
30405116
Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease.
Cell Death Dis
2018
29875626
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.
Front Neurosci
2018
25761946
The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
Neuroscientist
2016
27917109
Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.
Front Mol Neurosci
2016
26799652
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy
2016
26394101
Neurodegeneration: The Size Takes It All.
Curr Biol
2015
24243558
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Ann Neurol
2014
24922073
DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.
Cell Death Dis
2014
24686337
BAX channel activity mediates lysosomal disruption linked to Parkinson disease.
Autophagy
2014
22858546
Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency.
Cell Death Differ
2013
23884809
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Brain
2013
21619488
Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond.
Antioxid Redox Signal
2012
22885599
Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove.
Autophagy
2012
22647602
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.
Proc Natl Acad Sci U S A
2012
22355801
Mitochondrial biology and Parkinson's disease.
Cold Spring Harb Perspect Med
2012
22076440
Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
Hum Mol Genet
2012
22108613
Neurotoxin-based models of Parkinson's disease.
Neuroscience
2012
20695011
Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins.
Ann Neurol
2010
20844148
Pathogenic lysosomal depletion in Parkinson's disease.
J Neurosci
2010
18680555
Mitochondrial alterations in Parkinson's disease: new clues.
J Neurochem
2008
18595766
Molecular pathways of programmed cell death in experimental Parkinson's disease.
Parkinsonism Relat Disord
2008
18687899
The kinase domain of mitochondrial PINK1 faces the cytoplasm.
Proc Natl Acad Sci U S A
2008
17483459
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease.
Proc Natl Acad Sci U S A
2007
17766438
DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.
Proc Natl Acad Sci U S A
2007
16014720
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
J Neurosci
2005
16239214
Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.
J Biol Chem
2005
16365298
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.
Proc Natl Acad Sci U S A
2005
16389312
Toxin-induced models of Parkinson's disease.
NeuroRx
2005
15377875
MPTP as a mitochondrial neurotoxic model of Parkinson's disease.
J Bioenerg Biomembr
2004
15236401
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
Ann Neurol
2004
12850429
The rotenone model of Parkinson's disease.
Trends Neurosci
2003
12975474
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.
J Clin Invest
2003
12950442
Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
J Neurochem
2003
12079401
Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.
Neurobiol Dis
2002
12351746
Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat.
J Neurosci
2002
12473092
AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.
Eur J Neurosci
2002
11965178
[A patient with white matter involvement and superficial hemosiderosis of the central nervous system].
Rev Neurol (Paris)
2002
10651888
Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.
Eur J Neurosci
2000
10716902
Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
Exp Neurol
2000
11043563
Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion.
Neuroreport
2000
11052224
Metabolic effects of nigrostriatal denervation in basal ganglia.
Trends Neurosci
2000
1 - 46 of 46
Column Actions
Search
Recommended Authors
Jeha Jeon
Department of Psychiatry and McLean Hospital, Harvard Medical School
Career Start Year
2014
Number of shared co-authors
0
Abinaya Ravisankar
Center for Systems and Therapeutics, J. David Gladstone Institutes
Career Start Year
2014
Number of shared co-authors
3
Dorit Trudler
Tel Aviv University
Career Start Year
2010
Number of shared co-authors
0
Nima Dolatabadi
The Scripps Research Institute
Career Start Year
2010
Number of shared co-authors
0
Adam L Orr
Appel Alzheimer's Disease Research Institute
Career Start Year
2008
Number of shared co-authors
1
Nicolas Casadei
Institute of Medical Genetics and Applied Genomics, University of Tubingen
Career Start Year
2007
Number of shared co-authors
0
Kelly E Glajch
Neurodegenerative Diseases Research Unit
Career Start Year
2006
Number of shared co-authors
0
Merina Varghese
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2005
Number of shared co-authors
0
Ian Martin
Jungers Center for Neurosciences, Oregon Health and Science University
Career Start Year
2003
Number of shared co-authors
2
Jun Peng
College of Animal Science and Technology, Huazhong Agricultural University
Career Start Year
2002
Number of shared co-authors
0
Gaia Skibinski
Center for Systems and Therapeutics, J. David Gladstone Institutes
Career Start Year
1999
Number of shared co-authors
3
P Hemachandra Reddy
Texas Tech University Health Sciences Center
Career Start Year
1997
Number of shared co-authors
0
Ciro Iaccarino
University of Sassari
Career Start Year
1997
Number of shared co-authors
6
Eugene V Mosharov
Columbia University Medical Center, New York State Psychiatric Institute
Career Start Year
1996
Number of shared co-authors
9
Giselle M Petzinger
Keck School of Medicine, University of Southern California
Career Start Year
1995
Number of shared co-authors
0
Hyemyung Seo
Center for Bionano Intelligence Education and Research, Hanyang University
Career Start Year
1995
Number of shared co-authors
2
Giovanni Manfredi
Brain and Mind Research Institute
Career Start Year
1991
Number of shared co-authors
4
Lisa M Ellerby
Buck Institute for Research on Aging
Career Start Year
1990
Number of shared co-authors
47
Maria Manczak
Garrison Institute on Aging, Texas Tech University Health Sciences Center
Career Start Year
1989
Number of shared co-authors
0
Nicholas W Wood
UCL Queen Square Institute of Neurology
Career Start Year
1988
Number of shared co-authors
4
Eliezer Masliah
National Institute On Aging
Career Start Year
1986
Number of shared co-authors
6
Roger A Barker
John Van Geest Center for Brain Repair, University of Cambridge
Career Start Year
1986
Number of shared co-authors
3
Michael W Jakowec
Keck School of Medicine, University of Southern California
Career Start Year
1985
Number of shared co-authors
0
Russell H Swerdlow
University of Kansas Alzheimer's Disease Research Centre
Career Start Year
1984
Number of shared co-authors
1
Mya C Schiess
McGovern Medical School at UTHealth
Career Start Year
1982
Number of shared co-authors
0
Jeffrey H Kordower
ASU-Banner Neurodegenerative Disease Research Center, Arizona State University
Career Start Year
1981
Number of shared co-authors
1
Caroline M Tanner
UCSF School of Medicine and San Francisco VA Health Care System
Career Start Year
1980
Number of shared co-authors
1
Michelle E Ehrlich
Icahn School of Medicine at Mount Sinai
Career Start Year
1980
Number of shared co-authors
3
Steven M Hersch
Inc. University Avenue
Career Start Year
1980
Number of shared co-authors
2
David G Standaert
University of Alabama at Birmingham
Career Start Year
1977
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Mathieu Bourdenx
University College London, UK Dementia Research Institute
Co-authored papers
3
Valina L Dawson
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers
2
Harry Ischiropoulos
Co-authored papers
2
Ted M Dawson
Johns Hopkins University School of Medicine
Co-authored papers
2
Jeffery S Cox
University of California berkeley
Co-authored papers
2
Ian G Mills
Queen's University Belfast
Co-authored papers
1
Ekihiro Seki
Co-authored papers
1
William T Dauer
Peter O'Donnell Jr. Brain Institute
Co-authored papers
1
Ezra E W Cohen
university of california san diego Health System
Co-authored papers
1
Nikolai Slavov
and Barnett Institute, Northeastern University
Co-authored papers
1
Robert Nichols
University of California berkeley
Co-authored papers
1
Laura Caberlotto
The Microsoft Research University of Trento
Co-authored papers
1
Juan Fueyo
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
1
Nikolai V Gorbunov
Armed Forces Radiobiology Research Institute
Co-authored papers
1
J. Wade Harper
Harvard Medical School
Co-authored papers
1
Alexandra Tsitsiklis
University of California san francisco
Co-authored papers
1
Jan Paul Medema
Oncode Institute
Co-authored papers
1
David M Sabatini
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Co-authored papers
1
Arianna L Kim
Co-authored papers
1
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers
1
David Sulzer
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers
1
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers
1
P Robert Beatty
School of Public Health, University of California berkeley
Co-authored papers
1
Manish K Aghi
University of California san francisco
Co-authored papers
1
Hirotaka Watada
Co-authored papers
1
Sara Cherry
University of Pennsylvania
Co-authored papers
1
Sarah Stanley
University of California berkeley
Co-authored papers
1
Peter Robin Hiesinger
Co-authored papers
1
Hermann Pavenstädt
Co-authored papers
1
Volker D??tsch
Institute for Biophysical Chemistry, Goethe-University
Co-authored papers
1
1 - 30